期刊文献+

7523例酒钢一线职工健康体检脂肪肝检出情况分析及对策

7523 example kiuchuan steel works staff healthy physical examination fatty liver picks out the situation analysis and countermeasure
原文传递
导出
摘要 目的:了解钢铁企业一线职工脂肪肝的患病情况及相关因素,探讨脂肪肝的防治及干预措施.方法:对本院健康体检的7523例酒钢一线职工中脂肪肝患病率、超重或肥胖、血压、甘油三脂、血糖等检测结果进行分析.结果:脂肪肝检出率男性37.1%,女性10.8%.结论:酒钢一线职工脂肪肝的患病率较高,男性明显高于女性.脂肪肝与高血压、超重肥胖、高血脂等密切相关.对策 对钢铁企业职工要加强健康检查、普及健康教育、加强体育锻炼、改便不良生活方式,降低脂肪肝患病率,提高生活质量. Objective:Understood an iron and steel enterprise staff fatty liver is sick the situation and the correlation factor, dis- cusses the fatty liver preventing and controlling and the intervention measure. Methods:To a this courtyard healthy physical examination 7523 example kiuchuan steel works staff in the fatty liver prevalence rate, the overload or obese,examination results and so on blood pressure,glycerin,blood sugar carry on the analysis. Results: The fatty liver picks out rate the male 37. 1%, female 10.8%. Conclusion: A kiuchuan steel works staff fatty liver prevalence rate is high,the male is higher than the female obviously. Fatty liver and hypertension,overload obese, high blood fats and so on close correlation. The countermeasure must strengthen the automatic system checkout program, the popularization health education, the enhancement physical training to the iron and steel enterprise staff, changes then not the good life style,reduces the fatty liver prevalence rate,improves the quality of life.
作者 周虹 祁雪花
出处 《按摩与康复医学》 2011年第9期242-243,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 一线职工 健康体检 脂肪肝 分析与对策 A staff Healthy physical examination Fatty liver Analysis and countermeasure
  • 相关文献

参考文献2

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1519

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部